3 No-Brainer Growth Stocks to Buy for 2025 With $100 Right Now
Generated by AI AgentMarcus Lee
Saturday, Jan 11, 2025 10:23 am ET1min read
MORN--
As we approach 2025, investors are looking for growth stocks that can deliver significant returns. With a $100 investment, you can start building a portfolio of promising growth stocks. Here are three no-brainer growth stocks to consider for 2025, based on their strong fundamentals, undervalued prices, and growth potential.
1. Rentokil Initial (RTO)
Rentokil Initial is a leading provider of pest control and hygiene services, with a strong focus on market share leadership and geographic density. The company has completed over 200 acquisitions since 2015, reinforcing its economic moat and cost advantage. Rentokil Initial stock is trading at a 34% discount to Morningstar's fair value estimate of $39.50 per share, making it an attractive long-term investment opportunity.
2. Airbus (EADSY)
Airbus is a dominant player in the aerospace and defense industry, benefiting from its duopoly with Boeing in the market for aircraft with 130 seats and up. The company is well-positioned to take advantage of increasing commercial air travel and has a strong offering in the high end of the narrow-body market. Airbus stock is trading 16% below Morningstar's fair value estimate of $46 per share, presenting an opportunity for long-term investors.
3. AstraZeneca (AZN)
AstraZeneca is a leading drug manufacturer with a strong pipeline of innovative products. The company's focus on unmet needs and rigorous clinical trials has resulted in a wide economic moat and predictable cash flows. AstraZeneca stock is trading 15% below Morningstar's fair value estimate of $78 per share, making it an attractive long-term investment for growth-oriented investors.
These three growth stocks offer a combination of strong fundamentals, undervalued prices, and growth potential. By investing $100 in each of these stocks, you can build a diversified portfolio of high-quality growth stocks with the potential for significant long-term returns. Keep in mind that investing in individual stocks carries risks, and it's essential to maintain a well-diversified portfolio to manage those risks effectively.
RTO--
As we approach 2025, investors are looking for growth stocks that can deliver significant returns. With a $100 investment, you can start building a portfolio of promising growth stocks. Here are three no-brainer growth stocks to consider for 2025, based on their strong fundamentals, undervalued prices, and growth potential.
1. Rentokil Initial (RTO)
Rentokil Initial is a leading provider of pest control and hygiene services, with a strong focus on market share leadership and geographic density. The company has completed over 200 acquisitions since 2015, reinforcing its economic moat and cost advantage. Rentokil Initial stock is trading at a 34% discount to Morningstar's fair value estimate of $39.50 per share, making it an attractive long-term investment opportunity.
2. Airbus (EADSY)
Airbus is a dominant player in the aerospace and defense industry, benefiting from its duopoly with Boeing in the market for aircraft with 130 seats and up. The company is well-positioned to take advantage of increasing commercial air travel and has a strong offering in the high end of the narrow-body market. Airbus stock is trading 16% below Morningstar's fair value estimate of $46 per share, presenting an opportunity for long-term investors.
3. AstraZeneca (AZN)
AstraZeneca is a leading drug manufacturer with a strong pipeline of innovative products. The company's focus on unmet needs and rigorous clinical trials has resulted in a wide economic moat and predictable cash flows. AstraZeneca stock is trading 15% below Morningstar's fair value estimate of $78 per share, making it an attractive long-term investment for growth-oriented investors.
These three growth stocks offer a combination of strong fundamentals, undervalued prices, and growth potential. By investing $100 in each of these stocks, you can build a diversified portfolio of high-quality growth stocks with the potential for significant long-term returns. Keep in mind that investing in individual stocks carries risks, and it's essential to maintain a well-diversified portfolio to manage those risks effectively.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet